Cargando…

Methylphenidate-induced mania-like symptoms

Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit in a small number of cases. Signs and symptoms of adverse effects usually disappear on stopping the medicine. Data regarding the safety of methylphenidate in comorbid attention deficit hyperactivity di...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Kaustav, Grover, Sandeep
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062130/
https://www.ncbi.nlm.nih.gov/pubmed/21455430
http://dx.doi.org/10.4103/0253-7613.75678
_version_ 1782200694735896576
author Chakraborty, Kaustav
Grover, Sandeep
author_facet Chakraborty, Kaustav
Grover, Sandeep
author_sort Chakraborty, Kaustav
collection PubMed
description Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit in a small number of cases. Signs and symptoms of adverse effects usually disappear on stopping the medicine. Data regarding the safety of methylphenidate in comorbid attention deficit hyperactivity disorder (ADHD) and mental retardation are nonexistent. We describe a case of an 11-year-old girl with ADHD and mental retardation treated with methylphenidate, who developed mania like symptoms requiring inpatient treatment. The index case required psychopharmacological intervention with sodium valproate and olanzapine as the symptoms did not subside even after 3 days. This case highlights the fact that one has to exercise caution while prescribing methylphenidate in patients with comorbid ADHD and mental retardation.
format Text
id pubmed-3062130
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30621302011-03-31 Methylphenidate-induced mania-like symptoms Chakraborty, Kaustav Grover, Sandeep Indian J Pharmacol Drug Watch Therapeutic dose of methylphenidate is known to cause adverse effects (psychosis or mania), albeit in a small number of cases. Signs and symptoms of adverse effects usually disappear on stopping the medicine. Data regarding the safety of methylphenidate in comorbid attention deficit hyperactivity disorder (ADHD) and mental retardation are nonexistent. We describe a case of an 11-year-old girl with ADHD and mental retardation treated with methylphenidate, who developed mania like symptoms requiring inpatient treatment. The index case required psychopharmacological intervention with sodium valproate and olanzapine as the symptoms did not subside even after 3 days. This case highlights the fact that one has to exercise caution while prescribing methylphenidate in patients with comorbid ADHD and mental retardation. Medknow Publications 2011-02 /pmc/articles/PMC3062130/ /pubmed/21455430 http://dx.doi.org/10.4103/0253-7613.75678 Text en © Indian Journal of Pharmacology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Drug Watch
Chakraborty, Kaustav
Grover, Sandeep
Methylphenidate-induced mania-like symptoms
title Methylphenidate-induced mania-like symptoms
title_full Methylphenidate-induced mania-like symptoms
title_fullStr Methylphenidate-induced mania-like symptoms
title_full_unstemmed Methylphenidate-induced mania-like symptoms
title_short Methylphenidate-induced mania-like symptoms
title_sort methylphenidate-induced mania-like symptoms
topic Drug Watch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062130/
https://www.ncbi.nlm.nih.gov/pubmed/21455430
http://dx.doi.org/10.4103/0253-7613.75678
work_keys_str_mv AT chakrabortykaustav methylphenidateinducedmanialikesymptoms
AT groversandeep methylphenidateinducedmanialikesymptoms